Bayesian Optimal Designs for Phase I Clinical Trials (Q3079157)

From MaRDI portal
Revision as of 21:48, 3 February 2024 by Import240129110113 (talk | contribs) (Added link to MaRDI item.)





scientific article
Language Label Description Also known as
English
Bayesian Optimal Designs for Phase I Clinical Trials
scientific article

    Statements

    Bayesian Optimal Designs for Phase I Clinical Trials (English)
    0 references
    0 references
    0 references
    0 references
    0 references
    1 March 2011
    0 references
    constrained optimal design
    0 references
    maximum tolerated dose
    0 references
    sequential design
    0 references

    Identifiers

    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references